Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BPMC Blueprint Medicines > Detailed Quotes

BPMC Blueprint Medicines

66.340
+3.220+5.10%
Close 09/27 16:00 ET
High
67.160
Open
64.600
Turnover
31.19M
Low
63.940
Pre Close
63.120
Volume
470.75K
Market Cap
3.96B
P/E(TTM)
Loss
52wk High
117.860
Shares
59.72M
P/E(Static)
Loss
52wk Low
43.460
Float Cap
3.89B
Bid/Ask %
100.00%
Historical High
125.610
Shs Float
58.68M
Volume Ratio
1.04
Historical Low
13.040
Dividend TTM
--
Div Yield TTM
--
P/B
5.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.80%
Amplitude
5.10%
Avg Price
66.257
Lot Size
1
Float Cap
3.89B
Bid/Ask %
100.00%
Historical High
125.610
Shs Float
58.68M
Volume Ratio
1.04
Historical Low
13.040
Dividend TTM
--
P/B
5.30
Dividend LFY
--
Turnover Ratio
0.80%
Amplitude
5.10%
Avg Price
66.257
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases, blood disorders, and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
CEO: Ms. Kathryn Haviland
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...